-
Mashup Score: 14
Results from the multisite PRO-TECT trial show that using electronic patient-reported outcomes symptom monitoring has positive effects for patients receiving outpatient treatment with palliative intent for advanced or metastatic cancer.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline Clinical Insights | JCO Oncology Practice - 18 hour(s) ago
This clinical insights article is derived from recommendations in Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline. This document is based on an ASCO Guideline and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. This article does not purport to suggest any particular course of medical treatment. Use of the guideline and this article are voluntary.
Source: ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
Check out our new clinical insights on Germline and Somatic Genomic Testing for Metastatic Prostate Cancer. This is a companion piece to the updated guideline, published online in the @JCOOP_ASCO. https://t.co/nLyjzyMM4e
-
-
Mashup Score: 29Registration Details - ASCO - 1 day(s) ago
location_on McCormick Place, Chicago, IL & Online Online registrations are processed securely and confirmed immediately by email. Below you will find information related to registration fees, special rate categories, registration changes, and cancellations. Want to receive your badge in the mail before the Meeting? Register by the early registration deadline! The ASCO Annual Meeting is cashless! If you would like to register onsite at the meeting, please contact our Meetings team if you need to use
Source: www.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
⏰ Also, a reminder that early registration for #ASCO25 ends tonight at 11:59 p.m. (ET)! Learn more: https://t.co/l7eoVHrsum https://t.co/OHp6jRrRAJ
-
-
Mashup Score: 5Fertility Preservation in People With Cancer: ASCO Guideline Clinical Insights | JCO Oncology Practice - 3 day(s) ago
This clinical insights article is derived from recommendations in Fertility Preservation in People with Cancer: ASCO Guideline Update. This document is based on an ASCO Guideline and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. This article does not purport to suggest any particular course of medical treatment. Use of the guideline and this article are voluntary. Please refer
Source: ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
Check out our new clinical insights on Fertility Preservation in People With Cancer. This is a companion piece to the updated guideline, published online in the @JCOOP_ASCO. Read full article. https://t.co/vmZ5KKym28
-
-
Mashup Score: 9
Dr. John Sweetenham, Dr. Larry Shulman, and Dr. Rebecca Maniago discuss the integration of clinical pathways and decision support tools into the cancer center workflow, challenges to implementation at the point of care, and the promise of AI to further unlock these tools for clinicians.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
On the latest episode of the ASCO Daily News Podcast, find out why it can be difficult for oncologists to integrate oncology clinical pathways into their workflow and how technological advances like AI can help: https://t.co/60GOVsrm5z https://t.co/wwPzYdEePg
-
-
Mashup Score: 17Appendix Cancer Is Not the Same as Colorectal Cancer: Implications for Systemic Chemotherapy - 7 day(s) ago
Historically, medical oncologists have treated patients with appendiceal adenocarcinoma with the same chemotherapy that would be used for patients with colorectal cancer, despite these diseases exhibiting strikingly different tumor identities and natural disease courses. Growing recognition that appendix cancer is a unique disease entity and an unmet oncologic need is increasing research investment in this orphan disease.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
ICYMI: @jpshen_md of @MDAndersonNews and @MikeFooteMD of @MSKCancerCenter discuss how appendix cancer differs from CRC and examine new potential targeted treatments: https://t.co/mO0HUidwSE #ASCODailyNews https://t.co/vcq5dyIRBS
-
-
Mashup Score: 13ASCO Guideline Update Calls for Omission of SLNB in Select Patients With Early-Stage Breast Cancer - 7 day(s) ago
A new ASCO clinical practice guideline update recommends that sentinel lymph node biopsy and axillary lymph node dissection be omitted from the treatment of select patients with early-stage breast cancer.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
For more on this new guideline, read in-depth analysis from #ASCODailyNews w/ commentary from Expert Panel co-chairs @MylinTorres of @WinshipAtEmory & @KClaraPark of @Brighamsurgery @DanaFarber: https://t.co/rezDSfX1tg https://t.co/xpIwcWm1cx https://t.co/wn4eBXKMCu
-
-
Mashup Score: 5De-escalating Treatment in De Novo Oligometastatic Prostate Cancer: Which Patients Benefit? - 10 day(s) ago
Small studies in prostate cancer suggest that intermittent androgen deprivation therapy (ADT) or treatment breaks may be a viable option for select patients with sustained remission and no radiographic evidence of disease. Ongoing clinical trials are investigating strategies to balance the benefits of ADT in controlling prostate cancer with the need to mitigate treatment-related adverse effects and improve patient quality of life.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
ICYMI: Small studies in prostate cancer suggest that intermittent androgen deprivation therapy or treatment breaks may be an option for certain patients. @jordanciuro, @bilenma & Dr. Shahid Ahmed discuss de-escalation decisions for #ASCODailyNews: https://t.co/uY2roGb35O https://t.co/Xgtqtss80k
-
-
Mashup Score: 67The Evolution of the ASCO Educational Book and the Issues Shaping the Future of Oncology | ASCO Publications - 10 day(s) ago
On the inaugural episode of ASCO Education: By the Book, Dr. Nathan Pennell and Dr. Don Dizon share reflections on the evolution of the ASCO Educational Book, its global reach, and the role of its new companion podcast to further shine a spotlight on the issues shaping the future of modern oncology.
Source: ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
Listen to our inaugural episode of ASCO Education: By the Book. This episode features @n8pennell of @ClevelandClinic & Dr. Don Dizon of @BrownUniversity reflecting on the evolution of the #ASCOEducationalBook & highlight the launch its companion podcast. https://t.co/2dY4m8c2hX
-
-
Mashup Score: 67The Evolution of the ASCO Educational Book and the Issues Shaping the Future of Oncology | ASCO Publications - 10 day(s) ago
On the inaugural episode of ASCO Education: By the Book, Dr. Nathan Pennell and Dr. Don Dizon share reflections on the evolution of the ASCO Educational Book, its global reach, and the role of its new companion podcast to further shine a spotlight on the issues shaping the future of modern oncology.
Source: ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
Listen to our inaugural episode of ASCO Education: By the Book. This episode features @n8pennell of @ClevelandClinic & Dr. Don Dizon of @BrownUniversity reflecting on the evolution of the #ASCOEducationalBook & highlight the launch its companion podcast. https://t.co/2dY4m8c2hX
-
Did you know ePROs can improve patient care & provider workflows? A new study dives into the benefits & challenges of these systems. Read more on @ASCODailyNews: https://t.co/sCXDD7RQIv https://t.co/RJzmSRts6y